Insider · CIK 0001387660
Eric G Carter
Files at AEON (AEON Biopharma, Inc.). First filing -, latest -.
In brief
Eric G Carter files SEC Form 4 as director at AEON (AEON Biopharma, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Eric G Carter has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | AEON AEON Biopharma, Inc. | AGrant or award Class A Common Stock | +222,684 | $0.00 | $0 | 258,705 | Jun 22, 2026 |
| May 21, 2025 | AEON AEON Biopharma, Inc. | AGrant or award Restricted Stock Unitsderivative | +308,641 | $0.00 | $0 | 308,641 | May 23, 2025 |
Questions about Eric G Carter
Answered from the filings on this page, as of the latest one.
Is Eric G Carter buying or selling?
Eric G Carter has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Eric G Carter's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Eric G Carter has 0.
Where does Eric G Carter file Form 4?
Eric G Carter has filed Form 4 at AEON (AEON Biopharma, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.